Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.560
-0.210 (-11.86%)
At close: May 20, 2025, 4:00 PM
1.580
+0.020 (1.28%)
After-hours: May 20, 2025, 6:31 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $73.49 million as of May 20, 2025. Its market cap has decreased by -30.94% in one year.
Market Cap
73.49M
Enterprise Value
6.79M
1-Year Change
-30.94%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $73.49M, a decrease of -90.86%. That is a compound annual growth rate of -42.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 73.49M | -16.58% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |